Antidiabetic and hypolipidemic activity of Helicteres isora in animal models (Q40717149)

23 September 2017

Antidiabetic and hypolipidemic activity of Helicteres isora in animal models (English)

1 reference

23 September 2017

Helicteres isora

1 reference

Ranjan Chakrabarti

1

1 reference

23 September 2017

Reeba K Vikramadithyan

2

1 reference

23 September 2017

Ramesh Mullangi

3

1 reference

23 September 2017

V M Sharma

4

1 reference

23 September 2017

H Jagadheshan

5

1 reference

23 September 2017

Y N Rao

6

1 reference

23 September 2017

P Sairam

7

1 reference

23 September 2017

R Rajagopalan

8

1 reference

23 September 2017

language of work or name

1 reference

1 August 2002

1 reference

23 September 2017

7

1 reference

Journal of Ethnopharmacology

inferred from page(s)

published in

1 reference

23 September 2017

81

1 reference

23 September 2017

343-349

1 reference

23 September 2017

3

1 reference

Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes. American Diabetes Association

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900120-4

7 January 2021

New Pharmacological Approaches to Therapy of NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900120-4

7 January 2021

Pathogenesis of NIDDM. A balanced overview

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900120-4

7 January 2021

Insulin resistance in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900120-4

7 January 2021

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900120-4

7 January 2021

Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900120-4

7 January 2021

Design criteria for studies examining individual fatty acid effects on cardiovascular disease risk factors: human and animal studies

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900120-4

7 January 2021

The new antidiabetic drug MCC-555 acutely sensitizes insulin signaling in isolated cardiomyocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900120-4

7 January 2021

Insulin resistance and non-insulin-dependent diabetes mellitus: cellular and molecular mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900120-4

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900120-4

7 January 2021

Euglycemic and hypolipidemic activity of PAT5A: a unique thiazolidinedione with weak peroxisome proliferator activated receptor gamma activity

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900120-4

7 January 2021

Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900120-4

7 January 2021

Hepatic dysfunction associated with troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900120-4

7 January 2021

The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900120-4

7 January 2021

Evidence that multiple risk factors for coronary artery disease exist in persons with abnormal glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900120-4

7 January 2021

Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900120-4

7 January 2021

10.1016/S0378-8741(02)00120-4

Identifiers

DOI

1 reference

23 September 2017

1 reference